The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Trends Update — Commercialization by Nonprofit Foundations: iCo-CPDD Deal, plus MJFF Comes to Canada

One of the trends we’ve been keeping an eye on this year is the increasing willingness of nonprofit foundations to fund and support commercial product development.  Two updates today:

  1. iCo Therapeutics Inc. (TSX-V: ICO) is collaborating with the Consortium for Parasitic Drug Development (CPDD) to optimize one of iCo’s products for tropical conditions.  (That’s CPDD as in development of drugs to combat parasitic diseases, by the way, not a new and selfish approach to drug development.)  CPDD, a Bill & Melinda Gates Foundation grantee, is making an initial contribution of USD $182,930 to iCo’s work.
  2. The Michael J. Fox Foundation, which has been very active in providing funding to companies working on Parkinson’s treatments, has registered as a tax-exempt charity in Canada.  Hopefully this will open the door for more Canadian collaborations.

Bookmark and Share

About these ads

2 responses to “Trends Update — Commercialization by Nonprofit Foundations: iCo-CPDD Deal, plus MJFF Comes to Canada

  1. Pingback: Friday Science Review: September 25, 2009 « The Cross-Border Biotech Blog

  2. Pingback: Monday Deal Review: September 28, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers